RWM
ABBV icon

Riverbend Wealth Management’s AbbVie ABBV Stock Holding History

Riverbend Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
5,397
+1,544
+40% +$332K 0.68% 43
2026
Q1 		$838K Buy
3,853
+276
+8% +$61.2K 0.48% 59
2025
Q4 		$817K Buy
3,577
+227
+7% +$51.7K 0.51% 55
2025
Q3 		$776K Buy
3,350
+41
+1% +$8.35K 0.54% 50
2025
Q2 		$614K Buy
3,309
+245
+8% +$45.5K 0.47% 60
2025
Q1 		$642K Buy
3,064
+66
+2% +$12.8K 0.57% 49
2024
Q4 		$534K Buy
+2,998
New +$551K 0.48% 56

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Riverbend Wealth Management's ABBV Position: Q2 2026 in Review

Riverbend Wealth Management increased its AbbVie (ABBV) stake by 40% in Q2 2026, buying an estimated $332K and bringing the position to 5,397 shares worth $1.36M. The position accounts for 0.68% of the portfolio, ranked #43.

Riverbend Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,132 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Riverbend Wealth Management held 5,397 shares of AbbVie worth $1.36M as of Q2 2026.
  • Riverbend Wealth Management bought 1,544 AbbVie shares in Q2 2026, an estimated $332K.
  • AbbVie made up 0.68% of Riverbend Wealth Management's portfolio in Q2 2026, its #43 holding.
  • Riverbend Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,132 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riverbend Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.